PAUL ALLEN BRILL
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology ANDERSON, SC NPI 1528092673
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology SC NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$5,139.22
- Category: General Payments
- Program years: PY2018–2024
- Record count: 285
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,267.91 across 59 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,267.91 | 59 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $202.05 | 9 |
| ABBVIE INC. | $151.82 | 9 |
| EMD Serono, Inc. | $126.13 | 5 |
| Otsuka America Pharmaceutical, Inc. | $86.10 | 4 |
| UCB, Inc. | $78.73 | 3 |
| Amgen Inc. | $66.38 | 3 |
| Neurocrine BioSciences, Inc. | $64.86 | 3 |
| TG THERAPEUTICS, INC. | $46.48 | 2 |
| Lilly USA, LLC | $45.76 | 3 |
| ACADIA Pharmaceuticals Inc | $41.76 | 2 |
| Biogen, Inc. | $41.16 | 2 |
| ARGENX US, INC. | $40.04 | 1 |
| PFIZER INC. | $37.94 | 2 |
| Mallinckrodt Hospital Products Inc. | $36.10 | 1 |
| Lundbeck LLC | $31.99 | 2 |
| SK Life Science, Inc. | $28.48 | 1 |
| Abbott Laboratories | $28.12 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $22.44 | 1 |
| Neurelis, Inc. | $20.59 | 1 |
| Genentech USA, Inc. | $20.24 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.03 | 1 |
| Grifols USA, LLC | $16.90 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.81 | 1 |
By program year
Records — PY2024 (59)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.